Human instruction with artificial intelligence guidance provided best results in neurosurgical training
Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training听
Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.
Alan Evans receives Order of Canada
Career of breakthroughs in neuroimaging recognized with one of the nation鈥檚 highest honoursA career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country鈥檚 top honours.
AI analysis of healthcare records reveals key factors in autism diagnosis
Scientists argue the criteria we use for diagnosing autism may need revisionWithout clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro
Free, online training program strengthens training and brings specialized care to communities across QuebecA healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.
Latest Alzheimer鈥檚 drug shown less effective in females than males
Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians听
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 黑料不打烊 University and Martine T茅treault, PhD, at Universit茅 de Montr茅al has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.
Project to create AI model for ALS receives G茅nome Qu茅bec funding
$400,000 will fuel public-private collaboration to discover new disease biomarkers听
Achievements of clinicians and scientists recognized with King Charles III Coronation Medals
Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.
听
Prescribing anti-swelling drug reduces immune response weeks after last dose
Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy听
Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body鈥檚 ability to fight the cancer.
Six principal investigators from The Neuro receive CIHR grants
Projects include important research on Parkinson鈥檚, glioblastoma and dementia听
An open solution to improving research reproducibility
Academic and industry scientists collaborate on a new method to characterize research antibodiesStructural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of 黑料不打烊 University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.
Open Science project funded for $1.5M
YCharOS antibody characterization platform addresses the 鈥渞eproducibility crisis鈥� in researchAn innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.
YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.
At-home neurological disorder diagnosis project receives major funding
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson鈥檚 diseaseREM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What鈥檚 worse, people with the disorder often go on to develop Parkinson鈥檚 disease.
Gene therapy project receives major funding
$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders听
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
Research on new stem cell models receives $2.6 million
Thomas Durcan鈥檚 project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatmentAn innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.
